SUSHIL JAIN: Open Payments
NPI 1649247057 · FORT WAYNE, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,697 in 153 payments from 19 companies in 2025. Trend: 2023 $1,944 · 2024 $2,395 · 2025 $2,697
Food & beverage: $2,697
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 73 | $973 |
| Janssen Biotech, Inc. | 15 | $250 |
| Takeda Pharmaceuticals U.S.A., Inc. | 13 | $205 |
| Lilly USA, LLC | 5 | $200 |
| Gilead Sciences, Inc. | 9 | $181 |
| QOL Medical, LLC | 8 | $143 |
| GENZYME CORPORATION | 5 | $140 |
| Regeneron Healthcare Solutions, Inc. | 4 | $128 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 5 | $99 |
| Olympus America Inc. | 2 | $93 |
Products named: RINVOQ, DUPIXENT, TREMFYA, OMVOH, LINZESS, MAVYRET, Sucraid, CREON.
Industry payments across IN — which companies pay providers there.
